Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Biotech Growth reports on tough year as sector faces macro and political headwinds

Summary by QuotedData
Biotech Growth Trust (BIOG) has reported a disappointing set of annual results for the year ended 31 March 2025, with its net asset value (NAV) per share falling 24.4%, compared with a 6.0% decline for its benchmark, the NASDAQ Biotechnology Index (sterling-adjusted, total return). The trust’s share price fell 24.2%, closing the year on a […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

QuotedDataQuotedData

Biotech Growth reports on tough year as sector faces macro and political headwinds

Biotech Growth Trust (BIOG) has reported a disappointing set of annual results for the year ended 31 March 2025, with its net asset value (NAV) per share falling 24.4%, compared with a 6.0% decline for its benchmark, the NASDAQ Biotechnology Index (sterling-adjusted, total return). The trust’s share price fell 24.2%, closing the year on a […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

QuotedData broke the news in on Wednesday, June 4, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

United Kingdom icon

United Kingdom

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal